Company profile for FELIQS

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

FELIQS is a preclinical-stage biotechnology start-up, founded on pioneering research from Kyushu University. The company is focused on targeting a recently discovered form of cell death called ferroptosis, which is driven by the accumulation of oxidized lipids and implicated in major diseases like cancer, neurodegeneration, and ischemia. FELIQS has established a unique drug discovery platform targeting the ferroptosis pathway....
FELIQS is a preclinical-stage biotechnology start-up, founded on pioneering research from Kyushu University. The company is focused on targeting a recently discovered form of cell death called ferroptosis, which is driven by the accumulation of oxidized lipids and implicated in major diseases like cancer, neurodegeneration, and ischemia. FELIQS has established a unique drug discovery platform targeting the ferroptosis pathway. Leveraging this platform, the company is advancing novel therapeutics toward clinical trials, with an initial focus on creating breakthrough treatments for unmet medical needs in ophthalmology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
1-1 Hyakunenkoen, Kurume, Fukuoka, 8390864
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty